Take a 6th straight down day for the XBI biotech etf, the ridiculously tiny float for RLYP that exacerbates these up-and-down moves, and that bearish report from Elliot Flavus (who the hell is he?--Adam Feuerstein declared he adds nothing new to the bear view of MS analyst Andy Berens) -- and you get the kind of panicked capitulation (and fantastic buying opportunity, imo) seen early this a.m.
It would be nice to see RLYP close above its 50dma today (presently at 23.35), but since this week the stock seems for some reason to be closely tracking (being pushed around by) the XBI and general markets, we'll have to hope for a bit of a market rebound unless RLYP finally (and sanely) decouples from the markets.
Market Data 
Markets 
AI
